4.5. Minimise loss of genetic diversity across all threatened species and retain at least 95% gene diversity in species where it is already depleted.
Assessing and monitoring the genetic diversity of wild species has been relatively neglected until recently. Major advances in genetic and now genomic research have significantly increased the power of molecular analyses and reduced the costs. DNA analysis relies on well-equipped laboratories and trained scientific staff. Therefore, several monitoring and reporting approaches have been developed that use proxy measures where DNA data are not available. Such proxies may include effective population size, range contraction, fragmentation, and others. The headline CBD Indicator for the genetic component of Target 4 is “the proportion of the populations of a species that have an effective population size >500”. A recent study compared five proposed methods for monitoring genetic diversity, and recommended a scorecard system as a unified reporting mechanism by (O’Brien et al. 2022).
Subactions
-
4.5.1. Evaluate the loss in genetic diversity in populations of threatened species through genetic and genomic tools or proxy assessments.
-
4.5.2. Develop standardised genetic diversity indicators and reporting mechanisms for policy makers and conservation managers.
-
4.5.3. Use genetic and genomic analyses to inform integrated metapopulation management of ex situ and in situ populations and their role in reintroductions and reinforcement.
-
4.5.4. Include genetic risks in species Red List assessments.